Drug Profile
Monoclonal antibody LiCO 16-88
Latest Information Update: 29 Aug 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 29 Aug 2001 No-Development-Reported for Cancer in USA (IV)
- 14 Jul 1998 Profile reviewed
- 26 Jan 1995 Investigation in Cancer in USA (IV)